10-K

Annual Report

VANSEN PHARMA INC.

0001477932-13-001758

← back to feed

Filed

13 years ago Apr 12, 2013 12:00 AM ET

Period of report

—

On SEC.gov

Filing index ↗

Financials in this filing

Metric	Period	Value
Shares Outstanding	FY 2012 · Apr 12, 2013	3.53M sh
Operating Cash Flow	FY 2012 · Dec 31, 2012	−$28.75K
Operating Cash Flow	FY 2012 · Dec 31, 2012	−$216.19K
Operating Cash Flow	FY 2012 · Dec 31, 2011	−$20.42K
Cash And Equivalents	FY 2012 · Dec 31, 2012	$15.02K
Cash And Equivalents	FY 2012 · Dec 31, 2011	$18.77K
Cash And Equivalents	FY 2012 · Dec 31, 2010	$58
Stockholders Equity	FY 2012 · Dec 31, 2012	−$104.46K
Stockholders Equity	FY 2012 · Dec 31, 2011	−$98.78K
Stockholders Equity	FY 2012 · Dec 31, 2010	−$107.96K
Stockholders Equity	FY 2012 · Dec 31, 2009	−$81.13K
Stockholders Equity	FY 2012 · Dec 31, 2008	−$54.63K
Stockholders Equity	FY 2012 · Dec 31, 2007	−$35.66K
Stockholders Equity	FY 2012 · Dec 31, 2006	−$11.46K
Stockholders Equity restated	FY 2012 · Dec 31, 2005	−$4.81K
Current Liabilities	FY 2012 · Dec 31, 2012	$119.48K
Current Liabilities	FY 2012 · Dec 31, 2011	$117.55K
Total Liabilities	FY 2012 · Dec 31, 2012	$119.48K
Total Liabilities	FY 2012 · Dec 31, 2011	$117.55K
Current Assets	FY 2012 · Dec 31, 2012	$15.02K
Current Assets	FY 2012 · Dec 31, 2011	$18.77K
Total Assets	FY 2012 · Dec 31, 2012	$15.02K
Total Assets	FY 2012 · Dec 31, 2011	$18.77K
Sga Expense	FY 2012 · Dec 31, 2012	$13.34K
Sga Expense	FY 2012 · Dec 31, 2012	$58.76K
Sga Expense	FY 2012 · Dec 31, 2011	$7.13K
Net Income	FY 2012 · Dec 31, 2012	−$37.15K
Net Income	FY 2012 · Dec 31, 2012	−$250.07K
Net Income	FY 2012 · Dec 31, 2011	−$25.06K
Net Income	FY 2012 · Dec 31, 2010	−$31.6K
Net Income	FY 2012 · Dec 31, 2009	−$27.58K
Net Income	FY 2012 · Dec 31, 2008	−$24.54K
Net Income	FY 2012 · Dec 31, 2007	−$75.23K
Net Income	FY 2012 · Dec 31, 2006	−$22.77K
Net Income	FY 2012 · Dec 31, 2005	−$6.14K